secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2025-02-14T23:59:59+00:00
Accession:  0001104659-25-014165
Event type: leadership
Sentiment:  negative
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics terminates CEO James Sapirstein, appoints Richard Paolone as interim CEO
--------------------------------------------------------------------------------

- James Sapirstein terminated as CEO without cause effective February 12, 2025.
- Richard Paolone appointed interim CEO and Chairman, effective immediately.
- Paolone is a Toronto securities lawyer with board seats at multiple public companies.
- Paolone ceases to be independent director; Eric Corbett joins audit, governance, and compensation committees.
- Paolone's compensation as interim CEO to be determined at a later date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925014165/0001104659-25-014165-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925014165/tm256561d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-014165

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer